Cargando…
Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy
Biochemical analyses have characterized the BH3-only protein family member Noxa as a “sensitizer” with weak pro-apoptotic activity. Investigations into cancer cell responses to chemotherapeutic agents have identified Noxa as a pivotal factor mediating the cytotoxic effect of a plethora of anticancer...
Autores principales: | Albert, Marie-Christine, Brinkmann, Kerstin, Kashkar, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905168/ https://www.ncbi.nlm.nih.gov/pubmed/27308315 http://dx.doi.org/10.4161/mco.29906 |
Ejemplares similares
-
CHIP ubiquitylates NOXA and induces its lysosomal degradation in response to DNA damage
por: Albert, Marie-Christine, et al.
Publicado: (2020) -
Regulation of the DNA damage response by ubiquitin conjugation
por: Brinkmann, Kerstin, et al.
Publicado: (2015) -
Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
por: Brinkmann, K, et al.
Publicado: (2014) -
SAT-300 Evading Death: Noxa in Cushing’s Disease Pituitary Adenomas
por: Alvarez, Reinier, et al.
Publicado: (2020) -
Noxa mitochondrial targeting domain induces necrosis via VDAC2 and mitochondrial catastrophe
por: Han, Ji-Hye, et al.
Publicado: (2019)